ArticleThe Journal of clinical investigation2026

Tumor NLRP3 amplification promotes immunotherapy resistance by inhibiting STAT1 signaling and MHC class I expression.

Balamayroon Theivanthiran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.